Oragenics Inc. [AMEX: OGEN] stock went on an upward path that rose over 14.21% on Friday, amounting to a one-week price increase of more than 17.32%. The company report on April 9, 2021 that OGEN: COVID-19 Vaccine Candidate Exhibits Protective Immunity in Mice….
By David Bautz, PhD.
Over the last 12 months, OGEN stock rose by 110.80%. The average equity rating for OGEN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $79.97 million, with 109.65 million shares outstanding and 107.81 million shares in the current float. Compared to the average trading volume of 12.09M shares, OGEN stock reached a trading volume of 23213330 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Oragenics Inc. [OGEN]:
The Average True Range (ATR) for Oragenics Inc. is set at 0.08 The Price to Book ratio for the last quarter was 5.96, with the Price to Cash per share for the same quarter was set at 0.18.
OGEN Stock Performance Analysis:
Oragenics Inc. [OGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.32. With this latest performance, OGEN shares gained by 2.93% in over the last four-week period, additionally plugging by 54.93% over the last 6 months – not to mention a rise of 110.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OGEN stock in for the last two-week period is set at 50.29, with the RSI for the last a single of trading hit 56.71, and the three-weeks RSI is set at 48.50 for Oragenics Inc. [OGEN]. The present Moving Average for the last 50 days of trading for this stock 0.9659, while it was recorded at 0.7235 for the last single week of trading, and 0.7914 for the last 200 days.
Insight into Oragenics Inc. Fundamentals:
Return on Total Capital for OGEN is now -148.21, given the latest momentum, and Return on Invested Capital for the company is -150.00. Return on Equity for this stock declined to -155.13, with Return on Assets sitting at -137.54. When it comes to the capital structure of this company, Oragenics Inc. [OGEN] has a Total Debt to Total Equity ratio set at 5.34. Additionally, OGEN Total Debt to Total Capital is recorded at 5.07, with Total Debt to Total Assets ending up at 4.81. Long-Term Debt to Equity for the company is recorded at 5.11, with the Long-Term Debt to Total Capital now at 2.78.
Reflecting on the efficiency of the workforce at the company, Oragenics Inc. [OGEN] managed to generate an average of -$3,775,814 per employee.Oragenics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.40 and a Current Ratio set at 13.40.
OGEN Stock EPS
With the latest financial reports released by the company, Oragenics Inc. posted -0.11/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -37.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OGEN.
Oragenics Inc. [OGEN] Insider Position Details
There are presently around $7 million, or 9.00% of OGEN stock, in the hands of institutional investors. The top three institutional holders of OGEN stocks are: INDEPENDENT ADVISOR ALLIANCE with ownership of 4,200,000, which is approximately New of the company’s market cap and around 0.60% of the total institutional ownership; VANGUARD GROUP INC, holding 1,427,007 shares of the stock with an approximate value of $1.19 million in OGEN stocks shares; and SARA-BAY FINANCIAL, currently with $0.84 million in OGEN stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Oragenics Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 16 institutional holders increased their position in Oragenics Inc. [AMEX:OGEN] by around 4,546,852 shares. Additionally, 6 investors decreased positions by around 5,567,700 shares, while 8 investors held positions by with 1,584,872 shares. The mentioned changes placed institutional holdings at 8,529,680 shares, according to the latest SEC report filing. OGEN stock had 10 new institutional investments in for a total of 4,301,073 shares, while 3 institutional investors sold positions of 5,459,265 shares during the same period.